These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6980372)

  • 21. [Beta blocker prevention of hemorrhages from esophageal varices in liver cirrhosis].
    Hütteroth TH; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1983 Apr; 108(14):549-51. PubMed ID: 6132804
    [No Abstract]   [Full Text] [Related]  

  • 22. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
    Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY
    J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic prophylaxis in variceal bleeding to patients with liver cirrhosis? Yes!].
    Grønbaek H; Dahlerup JF; Ott P; Vilstrup H
    Ugeskr Laeger; 2005 Feb; 167(7):742-4. PubMed ID: 15779256
    [No Abstract]   [Full Text] [Related]  

  • 24. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
    Conn HO; Grace ND; Bosch J; Groszmann RJ; Rodés J; Wright SC; Matloff DS; Garcia-Tsao G; Fisher RL; Navasa M
    Hepatology; 1991 May; 13(5):902-12. PubMed ID: 2029994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group.
    Hepatology; 1991 Dec; 14(6):1016-24. PubMed ID: 1959848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of gastrointestinal bleeding in patients with cirrhosis].
    Sogni P
    Gastroenterol Clin Biol; 2000 Jan; 24(1):97-103. PubMed ID: 10679592
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomised trial of octreotide for long term management of cirrhosis after variceal hemorrhage.
    Sheikh RA; Trudeau WL
    Gastrointest Endosc; 1998 Sep; 48(3):328-30. PubMed ID: 9744619
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation.
    Gheorghe C; Gheorghe L; Iacob S; Iacob R; Popescu I
    Hepatogastroenterology; 2006; 53(70):552-7. PubMed ID: 16995460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic prophylaxis for patients with liver cirrhosis and upper gastrointestinal hemorrhage. Is there evidence for its use?].
    Kofoed K; Kronborg G
    Ugeskr Laeger; 2005 Feb; 167(7):735-9. PubMed ID: 15779254
    [No Abstract]   [Full Text] [Related]  

  • 30. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
    Schepke M; Kleber G; Nürnberg D; Willert J; Koch L; Veltzke-Schlieker W; Hellerbrand C; Kuth J; Schanz S; Kahl S; Fleig WE; Sauerbruch T;
    Hepatology; 2004 Jul; 40(1):65-72. PubMed ID: 15239087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Portacaval shunt as treatment for bleeding from esophageal varices in patients with liver cirrhosis].
    de Groote J; van Mieghem W; Cornette W; Vandenbroucke J
    Tijdschr Gastroenterol; 1971; 14(4):223-37. PubMed ID: 5316737
    [No Abstract]   [Full Text] [Related]  

  • 33. [Emergency treatment of bleeding esophageal varices in cirrhotic patients].
    Bosco L; Cossavella D; Vergani V; Rosato L
    Chir Ital; 1981 Jun; 33(3):704-11. PubMed ID: 6975666
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endoscopic sclerotherapy: does propranolol reduce the risk of hemorrhagic recurrence?].
    Blanc P
    Gastroenterol Clin Biol; 1994; 18(5):539-41. PubMed ID: 7813879
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of intravascular pressure in esophageal varices and the size of varices in patients with liver cirrhosis, with or without esophageal hemorrhage from the varices].
    Staritz M; Manns M; Poralla T; Dippold W; Hommel G; Meyer zum Büschenfelde KH
    Schweiz Rundsch Med Prax; 1985 Dec; 74(51):1425-6. PubMed ID: 3878990
    [No Abstract]   [Full Text] [Related]  

  • 38. [Can beta blockers prevent gastrointestinal bleeding from varices in cirrhotic patients?].
    Malè PJ
    Schweiz Rundsch Med Prax; 1984 Jun; 73(26):815-6. PubMed ID: 6147887
    [No Abstract]   [Full Text] [Related]  

  • 39. Erosive gastritis and acute gastro-duodenal ulcerations as source of upper gastrointestinal bleeding in liver cirrhosis.
    Glass GB; Khodadoost J
    Arch Fr Mal App Dig; 1972 Aug; 61(8):439-44. PubMed ID: 4539175
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
    Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.